|
|
<section data-role="paragraph" data-color="rgb(182, 228, 253)" data-custom="rgb(182, 228, 253)"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section><p><p><img src="image/20201014/86b79d371e9862b01189f0252a03b2cd_1.png" /></p></p></section><section><section><span><strong></strong></span></section><p><span>医疗器械媒体报道先锋</span></p><p><span>分享专业医疗器械知识</span></p></section><section><section><section>关注</section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section><section><section><section><span data-positionback="static"><p><img src="image/20201014/4e10c908b7214c0bc41a23af0b888bf2_2.png" /></p></span></section></section></section><p><strong><span>来源：</span></strong></p><p><span><strong><span><br /></span></strong></span></p><section><section powered-by="gulangu"><section><section><p>据了解到，全球随机抗生素包膜感染预防试验（WRAP-IT）的结果显示，Medtronic的Tyrx可吸收抗菌袋在心脏植入式电子患者中将重大感染风险降低了40％，交叉感染降低了61％设备（CIEDs）。这些改进与标准治疗前的抗生素相比。试验结果于3月16日至18日在新奥尔良举行的美国心脏病学会第68届年度科学会议（ACC.19）的最新会议上发表，并同时发表在《新英格兰医学杂志》上 。据了解，WRAP-IT是有史以来用心脏植入电子设备进行的最大的随机全球试验</p></section></section></section><section powered-by="gulangu"><section><section><p><br /></p></section></section></section><section powered-by="gulangu"><section><section><p><img src="image/20201014/7ec9dfa9d2ba4073c054aed4d8d36865_3.jpg" /></p></section></section></section><section powered-by="gulangu"><section><section><p><video width="100%" height="580" controls="controls"><source src="http://mpvideo.qpic.cn/tjg_3084203512_50000_0f359d94e2564eb986ae8515bd5fdff8.f10002.mp4?dis_k=e1a546761bb888294ef0f1cc95bbaefd&dis_t=1602656888" type="video/mp4"></source></video></p><p><br /></p><p>“CIED感染与显着的发病率，死亡率和成本相关。到目前为止，除了坚持严格的手术技术外，只有一种干预措施，术前抗生素，已被证明可以显着减少感染，“医学博士，公共卫生硕士，克利夫兰诊所心脏电生理学副主任，首席研究员Khaldoun Tarakji说。</p></section></section></section><section powered-by="gulangu"><section><section><p><img src="image/20201014/03035bebc1af14c8111afd0df3d9423b_4.png" /></p></section></section></section><section powered-by="gulangu"><section><section><p><span>Tyrx可吸收抗菌袋是一种网状袋子，可容纳植入式心脏装置或植入式神经刺激器。它被设计用于在植入后稳定装置，同时释放抗微生物剂，米诺环素和利福平，至少七天。在植入后约9周，袋子将完全被人体吸收。</span><span>Tyrx Envelope于2013年获得FDA认证，并于2014年获得CE 证。</span></p></section></section></section></section><p><br /></p><p><p><img src="image/20201014/cd6e6da350853c459044672a7cf353fb_5.jpg" /></p></p><section data-id="1658"><section><section><section data-id="1658"><section><section><section data-id="1658"><section><section><section data-id="1658"><section><section><p><span><strong>相关阅读</strong></span></p></section><p><p><img src="image/20201014/ec237188ae1e9c03eb4d9814f31b18ab_6.gif" /></p></p><p><br /></p><p><span>为什么美敦力、强生、GE、BD等医疗大佬都出自美国？</span><br /></p><p><br /></p><p><span>2000万美元！美敦力旗下的柯惠医疗将支付高额来解决回扣指控！</span><br /></p><p><br /></p><p><span>大开眼界！美敦力推出脊柱外科手术机器人Mazor X Stealth?</span><br /></p><p><br /></p><p><span>厉害了！ 美敦力将刷新全球最小心脏起搏器记录！</span></p></section></section></section></section></section></section></section></section></section></section></section>
|
|
发表于 2020-10-14 14:28:09